Literature DB >> 27730639

Insights into host-pathogen interactions from state-of-the-art animal models of respiratory Pseudomonas aeruginosa infections.

Anne Lorenz1, Vinay Pawar2,3,4, Susanne Häussler1,2, Siegfried Weiss3,4.   

Abstract

Pseudomonas aeruginosa is an important opportunistic pathogen that can cause acute respiratory infections in immunocompetent patients or chronic infections in immunocompromised individuals and in patients with cystic fibrosis. When acquiring the chronic infection state, bacteria are encapsulated within biofilm structures enabling them to withstand diverse environmental assaults, including immune reactions and antimicrobial therapy. Understanding the molecular interactions within the bacteria, as well as with the host or other bacteria, is essential for developing innovative treatment strategies. Such knowledge might be accumulated in vitro. However, it is ultimately necessary to confirm these findings in vivo. In the present Review, we describe state-of-the-art in vivo models that allow studying P. aeruginosa infections in molecular detail. The portrayed mammalian models exclusively focus on respiratory infections. The data obtained by alternative animal models which lack lung tissue, often provide molecular insights that are easily transferable to mammals. Importantly, these surrogate in vivo systems reveal complex molecular interactions of P. aeruginosa with the host. Herein, we also provide a critical assessment of the advantages and disadvantages of such models.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990P. aeruginosazzm321990; animal models; biofilm; host-pathogen interaction; in vivo infections

Mesh:

Substances:

Year:  2016        PMID: 27730639     DOI: 10.1002/1873-3468.12454

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Candida albicans and Pseudomonas aeruginosa Interact To Enhance Virulence of Mucosal Infection in Transparent Zebrafish.

Authors:  Audrey C Bergeron; Brittany G Seman; John H Hammond; Linda S Archambault; Deborah A Hogan; Robert T Wheeler
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

Review 2.  Transcriptional Profiling of Pseudomonas aeruginosa Infections.

Authors:  Janne G Thöming; Susanne Häussler
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 3.  The structure-function relationship of Pseudomonas aeruginosa in infections and its influence on the microenvironment.

Authors:  Mads Lichtenberg; Tim Holm Jakobsen; Michael Kühl; Mette Kolpen; Peter Østrup Jensen; Thomas Bjarnsholt
Journal:  FEMS Microbiol Rev       Date:  2022-09-02       Impact factor: 15.177

4.  Complementation of a metK-deficient E. coli strain with heterologous AdoMet synthetase genes.

Authors:  Gwenn G Parungao; Mojun Zhao; Qinzhe Wang; Stephen P Zano; Ronald E Viola; Robert M Blumenthal
Journal:  Microbiology       Date:  2017-11-07       Impact factor: 2.777

Review 5.  Recent advances in understanding Pseudomonas aeruginosa as a pathogen.

Authors:  Jens Klockgether; Burkhard Tümmler
Journal:  F1000Res       Date:  2017-07-28

6.  The therapeutic potential of bacteriocins as protein antibiotics.

Authors:  Hannah M Behrens; Anne Six; Daniel Walker; Colin Kleanthous
Journal:  Emerg Top Life Sci       Date:  2017-04-21

7.  In Vivo Evaluation of ECP Peptide Analogues for the Treatment of Acinetobacter baumannii Infection.

Authors:  Jiarui Li; Guillem Prats-Ejarque; Marc Torrent; David Andreu; Klaus Brandenburg; Pablo Fernández-Millán; Ester Boix
Journal:  Biomedicines       Date:  2022-02-05

8.  An iron-chelating sulfonamide identified from Drosophila-based screening for antipathogenic discovery.

Authors:  Yeon-Ji Yoo; In-Young Chung; Shivakumar S Jalde; Hyun-Kyung Choi; You-Hee Cho
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

9.  The Pseudomonas aeruginosa Complement of Lactate Dehydrogenases Enables Use of d- and l-Lactate and Metabolic Cross-Feeding.

Authors:  Yu-Cheng Lin; William Cole Cornell; Jeanyoung Jo; Alexa Price-Whelan; Lars E P Dietrich
Journal:  MBio       Date:  2018-09-11       Impact factor: 7.867

10.  A New PqsR Inverse Agonist Potentiates Tobramycin Efficacy to Eradicate Pseudomonas aeruginosa Biofilms.

Authors:  Christian Schütz; Duy-Khiet Ho; Mostafa Mohamed Hamed; Ahmed Saad Abdelsamie; Teresa Röhrig; Christian Herr; Andreas Martin Kany; Katharina Rox; Stefan Schmelz; Lorenz Siebenbürger; Marius Wirth; Carsten Börger; Samir Yahiaoui; Robert Bals; Andrea Scrima; Wulf Blankenfeldt; Justus Constantin Horstmann; Rebekka Christmann; Xabier Murgia; Marcus Koch; Aylin Berwanger; Brigitta Loretz; Anna Katharina Herta Hirsch; Rolf Wolfgang Hartmann; Claus-Michael Lehr; Martin Empting
Journal:  Adv Sci (Weinh)       Date:  2021-03-18       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.